Author:
Tu Zhenbo,Xiao Ruijing,Xiong Jie,Tembo Kingsley M.,Deng Xinzhou,Xiong Meng,Liu Pan,Wang Meng,Zhang Qiuping
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Molecular Biology,Hematology
Reference66 articles.
1. Weitzenfeld P, Ben-Baruch A. The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer. Cancer Lett. 2014;352(1):36–53.
2. Sharma S, Zhu L, Srivastava MK, Harris-White M, Huang M, Lee JM, et al. CCL21 chemokine therapy for lung cancer. Int Trends Immun. 2013;1(1):10–5.
3. Lazennec G, Richmond A. Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med. 2010;16(3):133–44.
4. Mukaida N, Baba T. Chemokines in tumor development and progression. Exp Cell Res. 2012;318(2):95–102.
5. Sarvaiya PJ, Guo D, Ulasov I, Gabikian P, Lesniak MS. Chemokines in tumor progression and metastasis. Oncotarget. 2013;4(12):2171–85.
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献